Proteomics International Laboratories Limited
Proteomics International Laboratories Limited (PIQ.AX) Company Profile & Overview
Explore Proteomics International Laboratories Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Proteomics International Laboratories Limited (PIQ.AX) Company Profile & Overview
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute and the Janssen Research & Development for the research of diabetic kidney disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma. The company was founded in 2001 and is based in Perth, Australia.